* This product is for research use only. Not intended for use in the treatment or diagnosis of disease.
|BT-000013||HepG2 Transfection Reagent||Inquiry|
|BT-000014||HepG2 CRISPR Transfection Reagent||Inquiry|
BOC Sciences' HepG2 Transfection Kit is optimized in HepG2 cells and enables a high-efficiency transfer of siRNA, miRNA or plasmid DNA into the cells.
HepG2 cells were derived from liver cancer tissue in a 15-year-old white man. The cells secrete a variety of plasma proteins: albumin, α2-Macroglobulin, plasminogen, transferrin, etc., and express 3-hydroxy-3-methylglutarate coenzyme A reductase and hepatic triglyceride lipase. In the presence of gramoxone, the expression of catalase mRNA was increased, and the expression of ApoA-I mRNA was decreased. The cells can be cultured in large volumes, negative for hepatitis B surface antigen, resistant to G418, and stimulatory to human growth hormone. Human hepatoma cell HEPG2 is the most common cancer in the world and the third leading cause of cancer death. HepG2 does not contain hepatitis B virus (HBV) and hepatitis C virus (HCV), so HepG2 is a commonly used cell line model to study HBV and HCV.
|HepG2 Transfection Reagent||HepG2 cell line||BOC Sciences HepG2 Transfection Reagent is a unique formulation based on cationic liposomes of non-animal origin. It is designed to transfect HepG2 cell line and is ideal for in vitro delivery of DNA and RNA.|
|HepG2 CRISPR Transfection Reagent||HepG2 cell line||BOC Sciences provides specially optimized HepG2 CRISPR transfection reagent, which is specially used to efficiently deliver the CRISPR/Cas9 system in the HepG2 cells to achieve efficient gene editing.|